3D‑Printed Nanocarriers Could Deliver Cancer Drugs Directly to Tumors and Reduce Harsh Side Effects

Chemotherapy remains one of the most widely used cancer treatments, but it often affects the entire body rather than just the tumor. Because these drugs target fast‑dividing cells, they also damage healthy tissues like hair follicles, the digestive tract, and bone marrow. This is why patients frequently experience hair loss, nausea, fatigue, and other difficult side effects. Researchers at the University of Mississippi are exploring a new approach that could make cancer treatment far more targeted and far less punishing.

The Ole Miss team has developed tiny 3D‑printed drug carriers, called “spanlastics”, that can be implanted directly at a tumor site. Instead of circulating throughout the bloodstream, the medication stays concentrated where it is needed most. The study shows that these microscopic carriers can successfully deliver cancer‑fighting drugs to breast cancer cells in the lab.

The technology relies on a specialized 3D‑printing method known as FRESH printing, which allows the researchers to create soft, flexible structures capable of holding and releasing medication. Each spanlastic capsule measures only 200 to 300 nanometers — thousands of times smaller than the width of a human hair. Their tiny size allows them to slip through cell membranes and deliver a high dose of medication directly inside cancer cells, where the drugs can act on DNA, RNA, or other critical pathways.

This direct‑delivery approach offers two major advantages. First, it protects the drug from breaking down before it reaches the tumor. Second, it reduces exposure to the rest of the body, which could dramatically cut down on side effects. The researchers believe this method could be especially valuable for early‑stage cancers, when tumors are still localized and easier to target.

While the results are promising, the team emphasizes that this work is still in the early stages. So far, the experiments have been conducted only in cell cultures. The next step will be testing the 3D‑printed carriers in animal models to understand how they behave inside the body and whether they can safely and effectively treat tumors.

If future studies are successful, this approach could offer a new way to deliver chemotherapy: one that is more precise, more effective, and far easier on patients. The combination of 3D printing and nanomedicine could eventually lead to personalized implants designed for specific tumor locations, giving doctors a new tool to fight cancer with fewer trade‑offs.